Three different bradycardic agents, zatebradine, diltiazem and propranolol, distinctly modify heart rate variability and QT-interval variability

Pharmacology

Volumn 80, Issue 4, 2007, Pages 293-303

  Yamabe, Motoko ^a   Sanyal, Shamarendra N ^a   Miyamoto, Shinji ^a   Hadama, Tetsuo ^a   Isomoto, Shojirou ^a   Ono, Katsushige ^a  

^a OITA UNIVERSITY   (Japan)

Author keywords

Autonomic nervous system; Diltiazem; Heart rate variability; Propranolol; QT variability; Zatebradine

Indexed keywords

DILTIAZEM; PROPRANOLOL; ZATEBRADINE;

ALGORITHM; ANTIARRHYTHMIC ACTIVITY; ARTICLE; COMPREHENSION; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; FOURIER ANALYSIS; GUINEA PIG; HEART RATE; HEART RATE VARIABILITY; HUMAN; MALE; NONHUMAN; PRIORITY JOURNAL; QT INTERVAL;

ADRENERGIC BETA-ANTAGONISTS; ANIMALS; BENZAZEPINES; CALCIUM CHANNEL BLOCKERS; DILTIAZEM; ELECTROCARDIOGRAPHY; GUINEA PIGS; HEART RATE; MALE; PROPRANOLOL;

EID: 35048843341     PISSN: 00317012     EISSN: None     Source Type: Journal    
DOI: 10.1159/000107103     Document Type: Article

References (48)

1. Atiga WL, Calkins H, Lawrence JH, Tomaselli GF, Smith JM, Berger RD: Beat-to-beat repolarization lability identifies patients at risk for sudden cardiac death. J Cardiovasc Electrophysiol 1998;9:899-908.
2. Akita M, Ishii K, Kuwahara M, Tsubone H: Power spectral analysis of heart rate variability for assessment of diurnal variation of autonomic nervous activity in guinea pigs. Exp Anim 2002;51:1-7.
3. Akita M, Kuwahara M, Nishibata R, Mikami H, Tsubone H: The daily pattern of heart rate, body temperature, locomotor activity, and autonomic nervous activity in congenitally bronchial-hypersensitive (BHS) and bronchial- hyposensitive (BHR) guinea pigs. Exp Anim 2004;53:121-127.
4. Belova NY, Mihaylov SV, Piryova BG: Wavelet transform: a better approach for the evaluation of instantaneous changes in heart rate variability. Auton Neurosci 2007;131:107-122.
5. Hosein-Sooklal A, Kargol A: Wavelet analysis of nonequilibrium ionic currents in human heart sodium channel (hH1a). J Membr Biol 2002;188:199-212.
6. Tsai ML, Shann WC, Luo WR, Yen CT: Wavelet-based analysis of low-frequency fluctuations of blood pressure and sympathetic nerve activity in rats. Neurosci Lett 2004;358:165-168.
7. Choi BR, Liu T, Salama G: The distribution of refractory periods influences the dynamics of ventricular fibrillation. Circ Res 2001;88:e49-e58.
8. Vassalle M, Yu H, Cohen IS: Pacemaker channels and cardiac automaticity; in Zipes DP, Jalife J (eds): Cardiac Electrophysiology from Cell to Bedside, ed 3, revised. Philadelphia, Saunders, 2000, pp 94-103.
9. f Current Inhibition. Adv Cardiol. Basel, Karger, 2006;43, pp 17-30.
10. f Current Inhibition. Adv Cardiol. Basel, Karger, 2006;43, pp 31-44.
11. Thollon C, Cambarrat C, Vian J, Prost JF, Peglion JL, Vilaine JP: Electrophysiological effects of S 16257, a novel sino-atrial node modulator, or rabbit and guinea-pig cardiac preparations: comparison with UL-FS 49. Br J Pharmacol 1994;112:37-42.
12. Satoh TO, Yamada M: Multiple inhibitory effects of zatebradine (UL-FS 49) on the electrophysiological properties of retinal rod photoreceptors. Pflügers Arch 2002;443:532-540.
13. Furukawa Y, Xue YX, Chiba S, Hashimoto K: Effects of zatebradine on ouabain-, two-stage coronary ligation- and epinephrine-induced ventricular tachyarrhythmias. Eur J Phamacol 1996;300:203-210.
14. Khaykin Y, Dorian P, Tang A, Green M, Mitchell J, Wulffhart Z, Newman D: The effect of sinus node depression on heart rate variability in humans using zatebradine, a selective bradycardic agent. Can J Physiol Pharmacol 1998;76:806-809.
15. Kanaya S, Arlock P, Katzung BG, Hondeghem LM: Diltiazem and verapamil preferentially block inactivated cardiac calcium channels. J Mol Cell Cardiol 1983;15:145-148.
16. 2+ channels. Eur J Phamacol 1998;358:277-287.
17. Tritthart HA: Mechanisms of action of calcium antagonists; in Sperelakis N, Kurachi Y, Terzic A, Cohen MV (eds): Heart Physiology and Pathophysiology, ed 4, revised. San Diego, Academic Press, 2001, pp 789-803.
18. Hart J, Wilkinson MF, Kelly MEM, Barnes S: Inhibitory action of diltiazem on voltage-gated calcium channels in cone photoreceptors. Exp Eye Res 2003;76:597-604.
19. 2+ transport; in Sperelakis N, Kurachi Y, Terzic A, Cohen MV (eds): Heart Physiology and Pathophysiology, ed 4, revised. San Diego, Academic Press, 2001, pp 447-460.
20. Lomansney JW, Allen LF: Adrenergic receptors in the cardiovascular system; in Sperelakis N, Kurachi Y, Terzic A, Cohen MV (eds): Heart Physiology and Pathophysiology, ed 4, revised. San Diego, Academic Press, 2001, pp 599-608.
21. Pelleg A, Vassort G, Auchampach JA: ATP and adenosine signal transductions; in Sperelakis N, Kurachi Y, Terzic A, Cohen MV (eds): Heart Physiology and Pathophysiology, ed 4, revised. San Diego, Academic Press, 2001, pp 633-655.
22. Stein PK, Bosner MS, Kleiger RE, Conger BM: Heart rate variability: a measure of cardiac autonomic tone. Am Heart J 1994;127:1376-1381.
23. Akselrod S, Gordon D, Ubel FA, Shannon DC, Barger AC, Cohen RJ: Power spectrum analysis of heart rate fluctuation: a quantitative probe of beat-to-beat cardiovascular control. Science 1981;213:220-222.
24. Bellavere F, Balzani I, De Masi G, Carraro M, Carenza P, Cobelli C, Thomaseth K: Power spectral analysis of heart-rate variations improves assessment of diabetic cardiac autonomic neuropathy. Diabetes 1992;41:633-640.
25. Hashimoto M, Kuwahara M, Tsubone H, Sugano S: Diurnal variation of autonomic nervous activity in the rat. Investigation by power spectral analysis of heart rate variability. J Electrocardiol 1999;32:167-171.
26. Krüger C, Landerer V, Zugck C, Ehmke H, Kübler W, Haass M: The bradycardic agent zatebradine enhances baroreflex sensitivity and heart rate variability in rats early after myocardial infarction. Cardiovasc Res 2000;45:900-912.
27. Bekheit S, Tangella M, El-Sakr A, Rasheed Q, Craelius W, El-Sherif N: Use of heart rate spectral analysis to study the effects of calcium channel blockers on sympathetic activity after myocardial infarction. Am Heart J 1990;119:79-85.
28. Cook JR, Bigger JT, Kleiger RE, Fleiss JL, Steinman RC, Rolnitzky LM: Effect of atenolol and diltiazem on heart period variability in normal persons. J Am Coll Cardiol 1991;17:480-484.
29. Brouwer J, Viersma JW, Van Veldhuisen DJ, Man in't Veld AJ, Sijbring P, Haaksma J, Dijk WA, Lie KI: Usefulness of heart rate variability in predicting drug efficacy (metoprolol vs diltiazem) in patients with stable angina pectoris. Am J Cardiol 1995;76:759-763.
30. Sung RJ, Shapiro WA, Shen EN, Morady F, Davis J: Effects of verapamil on ventricular tachycardias possibly caused by reentry, automaticity, and triggered activity. J Clin Invest 1983;72:350-360.
31. Ito M, Maeda Y, Arita M, Ito S, Saikawa T, Omura I, Fujino T, Fukumoto T, Kikuchi Y, Yamada K, Yanaga T: Effects of oral diltiazem on ventricular premature contractions. J Electrocardiol 1986;19:59-66.
32. Pagani M, Lombardi F, Guzzetti S, Rimoldi O, Furlan R, Pizzinelli P, Sandrone G, Malfatto G, Dell'Orto S, Piccaluga E, Turiel M, Baselli G, Cerutti S, Malliani A: Power spectral analysis of heart rate and arterial pressure variabilities as a marker of sympathovagal interaction in man and conscious dog. Circ Res 1986;59:178-193.
33. Beckers F, Verheyden B, Ramaekers D, Swynghedauw B, Aubert AE: Effects of autonomic blockade on non-linear cardiovascular variability indices in rats. Clin Exp Pharmacol Physiol 2006;33:431-439.
34. Koh J, Hidaka I, Miyata M: Effects of nicardipine and diltiazem on fractal features of short-term heart rate variability - application of coarse graining spectral analysis. J Anesth 2002;16:108-113.
35. Malliani A, Pagani M, Lombardi F, Cerutti S: Cardiovascular neural regulation explored in the frequency domain. Circulation 1991;84:482-492.
36. Berger RD: QT variability. J Electrocardiol 2003;36(suppl):83-87.
37. Nolan ER, Girand M, Bailie M, Yeragani VK: Circadian changes in the QT variability index in the beagle dog. Clin Exp Pharmacol Physiol 2004;31:783-785.
38. Zareba W, Bayes de Luna A: QT dynamics and variability. Ann Noninvasive Electrocardiol 2005;10:256-262.
39. Maison-Blanche P, Coumel P: Changes in repolarization dynamicity and the assessment of the arrhythmic risk. Pacing Clin Electrophysiol 1997;20:2614-2624.
40. Singh JP, Sleight P, Kardos A, Hart G: QT interval dynamics and heart rate variability preceding a case of cardiac arrest. Heart 1997;77:375-377.
41. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology: Heart rate variability: standards of measurement, physiological interpretation, and clinical use. Circulation 1996;93:1043-1065.
42. Ince C, Schulman SP, Quigley JF, Berger RD, Kolasa M, Ferguson R, Silver B, Haigney MCP: Usefulness of magnesium sulfate in stabilizing cardiac repolarization in heart failure secondary to ischemic cardiomyopathy. Am J Cardiol 2001;88:224-229.
43. Furukawa Y, Shimizu H, Hiromoto K, Kanemori T, Masuyama T, Ohyanagi M: Circadian variation of beat-to-beat QT interval variability in patients with prior myocardial infarction and effect of β-blocker therapy. Pacing Clin Electrophysiol 2006;29:479-486.
44. Wetzel GT, Brown JH: Presynaptic modulation of acetylcholine release from cardiac parasympathetic neurons. Am J Physiol 1985;248:H33-H39.
45. 1B subunit (CaV2.2) knockout mouse reveals a predominant role of N-type channels in the sympathetic regulation of the circulatory system. Trends Cardiovasc Med 2002;12:270-275.
46. Dobrev D, Milde AS, Andreas K, Ravens U: The effects of verapamil and diltiazem on N-, P- and Q-type calcium channels mediating dopamine release in rat striatum. Br J Pharm 1999;127:576-582.
47. 7 neuronal nicotinic receptors by ω-conotoxin MVIIC, ω-conotoxin GVIA and diltiazem. Br J Pharmacol 1999;127:1375-1387.
48. Bassett AL, Chakko S, Epstein M: Are calcium antagonists proarrhythmic? J Hypertens 1997;15:915-923.